Symmetry Medical, Inc. (SMA) Misses Q1 EPS by 9c; Guides FY13 EPS In-Line

Symmetry Medical, Inc. (NYSE: SMA) reported Q1 EPS of $0.06, $0.09 worse than the analyst estimate of $0.15. Revenue for the quarter came in at $98.9 million versus the consensus estimate of $106.04 million.

Symmetry Medical, Inc. sees FY2013 EPS of $0.64-0.76, versus the consensus of $0.71.

For earnings history and earnings-related data on Symmetry Medical, Inc. (SMA) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Is Treasury selloff a major issue for stock market bulls?
• UBS: 'We Believe Dollar Tree (DLTR) is Turning From a Transformation to a Growth Story'
• DA Davidson Reiterates Neutral Rating on Brunswick Corp (BC)